1. Home
  2. EHC vs PEN Comparison

EHC vs PEN Comparison

Compare EHC & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Encompass Health Corporation

EHC

Encompass Health Corporation

HOLD

Current Price

$107.50

Market Cap

12.4B

Sector

Health Care

ML Signal

HOLD

Logo Penumbra Inc.

PEN

Penumbra Inc.

HOLD

Current Price

$315.51

Market Cap

12.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHC
PEN
Founded
1983
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.4B
12.2B
IPO Year
1986
2015

Fundamental Metrics

Financial Performance
Metric
EHC
PEN
Price
$107.50
$315.51
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
15
Target Price
$141.88
$329.07
AVG Volume (30 Days)
1.0M
469.6K
Earning Date
02-05-2026
02-17-2026
Dividend Yield
0.70%
N/A
EPS Growth
27.89
367.34
EPS
5.29
4.14
Revenue
$5,795,600,000.00
$1,333,798,000.00
Revenue This Year
$11.54
$16.77
Revenue Next Year
$8.76
$14.12
P/E Ratio
$20.41
$76.09
Revenue Growth
11.13
14.61
52 Week Low
$87.85
$221.26
52 Week High
$127.99
$321.38

Technical Indicators

Market Signals
Indicator
EHC
PEN
Relative Strength Index (RSI) 37.01 63.72
Support Level $105.90 $307.00
Resistance Level $108.56 $319.78
Average True Range (ATR) 1.82 7.32
MACD 0.29 -0.82
Stochastic Oscillator 52.96 82.23

Price Performance

Historical Comparison
EHC
PEN

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

About PEN Penumbra Inc.

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Share on Social Networks: